PREVIOUS POSITIONS  

Post-doc at EPFL, Lausanne, Switzerland in the laboratory of Prof. Matthias Lutolf (2014-2016).  

Post-doc at San Raffaele, Milan, Italy in the laboratory of Dr. Vania Broccoli (2010-2014).

STUDIES  

Ph.D.: May 8th, 2009  Ph.D. in Molecular Medicine at the European School of Molecular Medicine (SEMM) (joint Ph.D. between University of Naples “Federico II” and University of Milan).  Title of experimental thesis: “Functions of the Krüppel-like Factor 7 protein in cellular differentiation and neuronal morphogenesis”. 

University: February 19th, 2004   Academic Degree (Laurea) in Biological Sciences with highest honour (110/110 cum laude) at “Federico II” University of Naples (Italy).   Title of experimental thesis: “Transcription factors involved in the dopaminergic neurons phenotype differentiation”.     

SELECTED GRANTS  

Health Holland TKI-LSH, ANKoRD, “Novel Multimodal Cancer Therapy by NK cell - Antibody Combination Therapy”. Project number: HH-PPS-24011-MKB.  

European Joint Program Rare Diseases 2019, URGENT, “Unveiling the role of glutamate in dopamine transporter deficiency syndrome” Project number: EJPRD19-220.  

Health Holland TKI-LSH, SPUNK, “A scalable synthetic RNA delivery platform for universal ex vivo modification of NK cells” Project number: LSHM19131.    

AWARDS  

Senior Research Qualification (SRQ)/Senior Kwalificatie Onderzoek (SKOz) at Utrecht University, January 24th 2025.  

University Teaching Qualification (UTQ)/ Basis Kwalificatie Onderwijs (BKO) at Utrecht University, January 26th 2021.  

Recipient of the European prize for young researchers in the field of neurodegenerative pathologies leading to dementia (Fondazione Gino Galletti Neuroscience Prize 2013).    

PATENTS  

Method to generate dopaminergic neurons from mouse and human cells. Broccoli V. & Caiazzo M. Patent number: PCT/EP2011/072608 December 13th 2011. WO 2012/080248 A1, June 21st 2012.  

Single-domain antibodies targeting the heparin binding Egf-like growth factor. Pompe S., Qiu B., Xenaki A.T., Caiazzo M., Van den Bergen en Henegouwen P. Patent number: P36735NL00/MJO, October 30th 2024.